Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02985346

Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis

Sun Yat-sen Memorial Hospital

Sponsor: Sun Yat-sen University

Conditions Idiopathic Pulmonary Hemosiderosis

Interventions Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis

Updated 6 times since 2017 Last updated: Dec 6, 2016 Started: Jan 31, 2017 Primary completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Idiopathic Pulmonary Hemosiderosis, this trial is ongoing. The trial is conducted by Sun Yat-sen University and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jan 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting Phase 0

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.